Antiviral and immunomodulatory effects of a novel bacterial exopolysaccharide of shallow marine vent origin

Abstract

The exopolysaccharide produced by B. licheniformis strain T14, stimulator of Th1 cell-mediated immunity, could be used as therapy in immunocompromised host.